Drug interactions of carbonic anhydrase inhibitors and activators
CT Supuran - Expert Opinion on Drug Metabolism & Toxicology, 2024 - Taylor & Francis
ABSTRACT Introduction Carbonic anhydrases (CAs, EC 4.2. 1.1) have been established
drug targets for decades, with their inhibitors and activators possessing relevant …
drug targets for decades, with their inhibitors and activators possessing relevant …
Therapeutic dilemmas: cognitive enhancers and risk of falling in older adults—a clinical review
GE Portlock, MD Smith, EP van Poelgeest… - European geriatric …, 2023 - Springer
Purpose Cognitive enhancers are the primary pharmacological therapy prescribed to those
with dementia, comprising of memantine and the acetylcholinesterase inhibitors (AChEIs) …
with dementia, comprising of memantine and the acetylcholinesterase inhibitors (AChEIs) …
[HTML][HTML] Memantine
B Kuns, A Rosani, P Patel, D Varghese - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Memantine - StatPearls - NCBI Bookshelf US flag An official website of the United States
government Here's how you know NIH NLM Logo Access keys NCBI Homepage MyNCBI …
government Here's how you know NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review
M Cocco, C Carnovale, E Clementi… - Expert Review of …, 2024 - Taylor & Francis
ABSTRACT Introduction Drug-drug interactions (DDIs) are defined as the pharmacological
effects produced by the concomitant administration of two or more drugs. To minimize false …
effects produced by the concomitant administration of two or more drugs. To minimize false …
Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
W Zhang, M Chen, X Cai, M Zhang, M Hu… - Expert Opinion on …, 2024 - Taylor & Francis
Background Despite its widespread use, the adverse effects (AEs) of memantine have not
been well documented, and there is a need to find new ways to analyze the AEs of …
been well documented, and there is a need to find new ways to analyze the AEs of …
[HTML][HTML] Association between Polypharmacy and Adverse Events in Patients with Alzheimer's Disease: An Analysis of the Japanese Adverse Drug Event Report …
N Otani, K Kanda, NR Ngatu, A Murakami, Y Yamadori… - Medicina, 2024 - mdpi.com
Background and Objectives: Alzheimer's disease is a global health concern, with a rising
prevalence among the elderly. Current pharmacological treatments, including …
prevalence among the elderly. Current pharmacological treatments, including …
Memantine decreases measures of sign-tracking and increases measures of goal-tracking in male Sprague Dawley rats
JM Holden - Learning and Motivation, 2022 - Elsevier
Memantine is a drug which has antagonistic effects at N-methyl-D-aspartate and 5-
hydroxytryptamine 3 receptors. Its properties may make it especially effective at reducing …
hydroxytryptamine 3 receptors. Its properties may make it especially effective at reducing …
Side effects of drugs used in the treatment of Alzheimer's disease
H Kandelshein, J Bloemer - Side effects of drugs annual, 2022 - Elsevier
Medications used in the treatment of Alzheimer's disease include the acetylcholinesterase
inhibitors (AChEIs, ie, donepezil, rivastigmine, and galantamine), the N-methyl-d-aspartate …
inhibitors (AChEIs, ie, donepezil, rivastigmine, and galantamine), the N-methyl-d-aspartate …
Time to onset of drug-induced parkinsonism: Analysis using a large Japanese adverse event self-reporting database
Whether there are differences in the time to onset of drug-induced parkinsonism (DIP)
depending on the type of drugs causing DIP remains uncertain, so that question was …
depending on the type of drugs causing DIP remains uncertain, so that question was …
Time to Onset of Drug-Induced Parkinsonism: Difference in Its Distribution by Drug Category
Introduction: It remains uncertain whether there may be differences in the time to onset of
drug-induced parkinsonism (DIP) depending on the type of drugs causing DIP, which we …
drug-induced parkinsonism (DIP) depending on the type of drugs causing DIP, which we …